Aehr Test Systems (AEHR) Competitors

Aehr Test Systems (NASDAQ:AEHR) and Transcat (NASDAQ:TRNS) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership and valuation.

Do analysts recommend AEHR or TRNS?

Aehr Test Systems currently has a consensus price target of $25.00, suggesting a potential upside of 187.03%. Transcat has a consensus price target of $111.50, suggesting a potential upside of 39.69%. Given Aehr Test Systems' stronger consensus rating and higher probable upside, research analysts clearly believe Aehr Test Systems is more favorable than Transcat.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aehr Test Systems	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Transcat	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Does the media favor AEHR or TRNS?

In the previous week, Transcat had 4 more articles in the media than Aehr Test Systems. MarketBeat recorded 5 mentions for Transcat and 1 mentions for Aehr Test Systems. Transcat's average media sentiment score of 1.54 beat Aehr Test Systems' score of 1.51 indicating that Transcat is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aehr Test Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Transcat	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more risk and volatility, AEHR or TRNS?

Aehr Test Systems has a beta of 2.21, suggesting that its share price is 121% more volatile than the S&P 500. Comparatively, Transcat has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500.

Which has stronger earnings & valuation, AEHR or TRNS?

Aehr Test Systems has higher earnings, but lower revenue than Transcat. Aehr Test Systems is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aehr Test Systems	$61.48M	4.22	$33.16M	$0.78	11.17
Transcat	$272.20M	2.73	$13.65M	$1.85	43.15

Is AEHR or TRNS more profitable?

Aehr Test Systems has a net margin of 43.41% compared to Transcat's net margin of 6.22%. Aehr Test Systems' return on equity of 21.09% beat Transcat's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aehr Test Systems	43.41%	21.09%	18.08%
Transcat	6.22%	7.23%	5.67%

Do institutionals & insiders have more ownership in AEHR or TRNS?

69.7% of Aehr Test Systems shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 6.2% of Aehr Test Systems shares are owned by company insiders. Comparatively, 2.3% of Transcat shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in AEHR or TRNS?

Transcat received 79 more outperform votes than Aehr Test Systems when rated by MarketBeat users. Likewise, 66.14% of users gave Transcat an outperform vote while only 58.15% of users gave Aehr Test Systems an outperform vote.

Company	Underperform	Outperform
Aehr Test Systems	Outperform Votes 132 58.15%	Underperform Votes 95 41.85%
Transcat	Outperform Votes 211 66.14%	Underperform Votes 108 33.86%

Summary

Aehr Test Systems and Transcat tied by winning 9 of the 18 factors compared between the two stocks.